Ovarian cancer: involvement of the matrix metalloproteinases

被引:79
|
作者
Al-Alem, Linah [1 ]
Curry, Thomas E., Jr. [1 ]
机构
[1] Univ Kentucky, Med Ctr, Dept Obstet & Gynecol, Lexington, KY 40536 USA
基金
美国国家卫生研究院;
关键词
PROGNOSTIC-SIGNIFICANCE; INCESSANT OVULATION; CLINICAL-RELEVANCE; PROMOTES INVASION; TISSUE INHIBITORS; SIGNALING SYSTEM; CARCINOMA CELLS; MESSENGER-RNA; EXPRESSION; ACTIVATION;
D O I
10.1530/REP-14-0546
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ovarian cancer is the leading cause of death from gynecologic malignancies. One of the reasons for the high mortality rate associated with ovarian cancer is its late diagnosis, which often occurs after the cancer has metastasized throughout the peritoneal cavity. Cancer metastasis is facilitated by the remodeling of the extracellular tumor matrix by a family of proteolytic enzymes known as the matrix metalloproteinases (MMPs). There are 23 members of the MMP family, many of which have been reported to be associated with ovarian cancer. In the current paradigm, ovarian tumor cells and the surrounding stromal cells stimulate the synthesis and/or activation of various MMPs to aid in tumor growth, invasion, and eventual metastasis. The present review sheds light on the different MMPs in the various types of ovarian cancer and on their impact on the progression of this gynecologic malignancy.
引用
收藏
页码:R55 / R64
页数:10
相关论文
共 50 条
  • [31] Involvement of matrix metalloproteinases and their tissue inhibitors in spondyloarthropathy synovitis
    Vandooren, B
    Kruithof, E
    Yu, DTY
    Rihl, M
    Gu, J
    De Rycke, L
    Van den Bosch, F
    Veys, EM
    De Keyser, F
    Baeten, D
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 400 - 400
  • [32] Involvement of matrix metalloproteinases (MMPs) in cutaneous melanoma progression
    Ntayi, C
    Hornebeck, W
    Bernard, P
    [J]. PATHOLOGIE BIOLOGIE, 2004, 52 (03): : 154 - 159
  • [33] The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas
    Koennecke, Helen
    Bechmann, Ingo
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,
  • [34] The role of the matrix metalloproteinases in human endometrial and ovarian cycles
    Goldman, S
    Shalev, E
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2003, 111 (02) : 109 - 121
  • [35] Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs)
    Henriet, P
    Cornet, PB
    Lemoine, P
    Galant, C
    Singer, CF
    Courtoy, PJ
    Eeckhout, Y
    Marbaix, E
    [J]. ENDOMETRIOSIS: EMERGING RESEARCH AND INTERVENTION STRATEGIES, 2002, 955 : 119 - 138
  • [36] Tissue inhibitors of matrix metalloproteinases in cancer
    Blavier, L
    Henriet, P
    Imren, S
    DeClerck, YA
    [J]. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 : 108 - 119
  • [37] Matrix metalloproteinases: protective roles in cancer
    Decock, Julie
    Thirkettle, Sally
    Wagstaff, Laura
    Edwards, Dylan R.
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (06) : 1254 - 1265
  • [38] Matrix Metalloproteinases In Cancer Biology: A Review
    Ibrahim, W. N.
    Rasad, Abdull M. S. B.
    Doolanea, A. A.
    [J]. INTERNATIONAL MEDICAL JOURNAL MALAYSIA, 2019, 18 (02) : 147 - 152
  • [39] Matrix metalloproteinases as therapeutic targets in cancer
    Vihinen, P
    Ala-aho, R
    Kähäri, VM
    [J]. CURRENT CANCER DRUG TARGETS, 2005, 5 (03) : 203 - 220
  • [40] Matrix metalloproteinases targeting in prostate cancer
    Zhu, Shuying
    He, Jing
    Yin, Liliang
    Zhou, Jiawei
    Lian, Jiayi
    Ren, Yanli
    Zhang, Xinling
    Yuan, Jinghua
    Wang, Gang
    Li, Xiaoping
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (09) : 275 - 287